Evotec SE (EVO) Acquisitions (2022 - 2023)
Evotec SE's (EVO) quarterly Acquisitions came in at $2.2 million in Q4 2023, up 110.55% year-over-year from $1.1 million in Q4 2022, and up 110.55% quarter-over-quarter from -$21.3 million in Q4 2022.
Powered by 
Analysis
Evotec SE (EVO) Acquisitions (2022 - 2023) Analysis & Trends
Evotec SE has disclosed Acquisitions across 2 years of filings, most recently posting $2.2 million for Q4 2023.
- In Q4 2023, Acquisitions rose 110.55% year-over-year to $2.2 million; the TTM figure through Dec 2023 stood at -$19.0 million (up 10.55% YoY), while the FY2023 annual figure was $2.3 million, up 110.27% from the prior year.
- Acquisitions came in at $2.2 million for Q4 2023 at Evotec SE, up from -$21.3 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $2.2 million in Q4 2023 to a low of -$21.3 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 163.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 62.25 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |